Literature DB >> 18818203

G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation.

Yelena Janumyan1, Qinghua Cui, Ling Yan, Courtney G Sansam, Mayda Valentin, Elizabeth Yang.   

Abstract

BCL2 and BCL-x(L) facilitate G(0) quiescence by decreasing RNA content and cell size and up-regulating p27 protein, but the precise mechanism is not understood. We investigated the relationship between cell cycle regulation and the anti-apoptosis function of BCL2 and BCL-x(L). Neither caspase inhibition nor abrogation of mitochondria-dependent apoptosis by BAX and BAK deletion fully recapitulated the G(0) effects of BCL2 or BCL-x(L), suggesting that mechanisms in addition to anti-apoptosis are involved in the cell cycle arrest function of BCL2 or BCL-x(L). We found that BCL2 and BCL-x(L) expression in bax(-/-) bak(-/-) cells did not confer cell cycle effects, consistent with the G(0) function of BCL2 and BCL-x(L) being mediated through BAX or BAK. Stabilization of p27 in G(0) in BCL2 or BCL-x(L) cells was due to phosphorylation of p27 at Ser(10) by the kinase Mirk. In bax(-/-) bak(-/-) cells, total p27 and p27 phosphorylated at Ser(10) were elevated. Re-expression of BAX in bax(-/-) bak(-/-) cells and silencing of BAX and BAK in wild type cells confirmed that endogenous BAX and BAK modulated p27. These data revealed a novel role for BAX and BAK in the regulation of G(0) quiescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818203      PMCID: PMC2590681          DOI: 10.1074/jbc.M806294200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability.

Authors:  N Ishida; M Kitagawa; S Hatakeyama; K Nakayama
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Caspase activity is required for stimulated B lymphocytes to enter the cell cycle.

Authors:  N Eric Olson; Jonathan D Graves; Geraldine L Shu; Elizabeth J Ryan; Edward A Clark
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

3.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

4.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

Authors:  A Strasser; A W Harris; M L Bath; S Cory
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

5.  Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity.

Authors:  Minna Woo; Razqallah Hakem; Caren Furlonger; Anne Hakem; Gordon S Duncan; Takehiko Sasaki; Denis Bouchard; Liwei Lu; Gillian E Wu; Christopher J Paige; Tak W Mak
Journal:  Nat Immunol       Date:  2003-09-14       Impact factor: 25.606

6.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

7.  The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.

Authors:  Xiaobing Deng; Stephen E Mercer; Sejal Shah; Daina Z Ewton; Eileen Friedman
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

8.  Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry.

Authors:  Yelena M Janumyan; Courtney G Sansam; Anuja Chattopadhyay; Ningli Cheng; Erinn L Soucie; Linda Z Penn; David Andrews; C Michael Knudson; Elizabeth Yang
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

Authors:  T J McDonnell; N Deane; F M Platt; G Nunez; U Jaeger; J P McKearn; S J Korsmeyer
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

10.  Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival.

Authors:  Ningli Cheng; Yelena M Janumyan; Lisa Didion; Chris Van Hofwegen; Elizabeth Yang; C Michael Knudson
Journal:  Oncogene       Date:  2004-05-06       Impact factor: 9.867

View more
  27 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

2.  The BCL2L1 and PGAM5 axis defines hypoxia-induced receptor-mediated mitophagy.

Authors:  Hao Wu; Danfeng Xue; Guo Chen; Zhe Han; Li Huang; Chongzhuo Zhu; Xiaohui Wang; Haijing Jin; Jun Wang; Yushan Zhu; Lei Liu; Quan Chen
Journal:  Autophagy       Date:  2014-07-17       Impact factor: 16.016

3.  Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo.

Authors:  Cindy T J van Velthoven; Antoine de Morree; Ingrid M Egner; Jamie O Brett; Thomas A Rando
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

4.  Bcl-2 delays cell cycle through mitochondrial ATP and ROS.

Authors:  Xing Du; Xufeng Fu; Kun Yao; Zhenwei Lan; Hui Xu; Qinghua Cui; Elizabeth Yang
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

Review 5.  Biomarkers of therapeutic response to BCL2 antagonists in cancer.

Authors:  Lloyd T Lam; Haichao Zhang; Brenda Chyla
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

6.  The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells.

Authors:  Stéphanie Brayer; Audrey Joannes; Madeleine Jaillet; Elisa Gregianin; Souhir Mahmoudi; Joëlle Marchal Sommé; Aurélie Fabre; Pierre Mordant; Aurélie Cazes; Bruno Crestani; Arnaud A Mailleux
Journal:  Cell Cycle       Date:  2017-09-21       Impact factor: 4.534

7.  When BAX doesn't kill.

Authors:  Ruoyao Chen; Michael Overholtzer
Journal:  Cell Cycle       Date:  2018-04-03       Impact factor: 4.534

8.  Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.

Authors:  Daina Z Ewton; Jing Hu; Maria Vilenchik; Xiaobing Deng; Kin-Chun Luk; Ann Polonskaia; Ann F Hoffman; Karen Zipf; John F Boylan; Eileen A Friedman
Journal:  Mol Cancer Ther       Date:  2011-08-30       Impact factor: 6.261

9.  Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle progression and checkpoints.

Authors:  Jianfang Wang; Myriam Beauchemin; Richard Bertrand
Journal:  Cell Signal       Date:  2011-08-05       Impact factor: 4.315

10.  BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.

Authors:  Mariarita Perri; Jeremy L Yap; Jianshi Yu; Erika Cione; Steven Fletcher; Maureen A Kane
Journal:  Exp Cell Res       Date:  2014-08-01       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.